Back to Results
| First Page | Meta Content | |
|---|---|---|
 | Document Date: 2009-09-17 07:47:14Open Document File Size: 1,35 MBShare Result on FacebookCityOxford / Seattle / Montevideo / Beit Shemesh / Jerusalem / Haifa / /CompanyEster Neuroscience / Merck KgaA / Novagali Pharma S.A. / SolGel Technologies Ltd / Norton Healthcare / Amarin Corp. / BioLineRx / De Ruiter / SyntheMed Inc. / Teva / Israel Healthcare Ventures / Johnson& Johnson / IHCV / Yissum / Sol-Gel / Skeletal Biotechnology Laboratory / Phenome Networks / the Tel Aviv Stock Exchange / PharmAthene Inc. / IVAX Corporation / Sol-Gel Technologies Ltd. / HumanEyes / Phenom Networks / Protalix BioTherapeutics Inc. / /ContinentEurope / /CountryUnited Kingdom / Israel / soviet union / Uruguay / France / Palestinian Territories / Germany / United States / /CurrencyUSD / EUR / /EventM&A / Product Release / Company Expansion / FDA Phase / Person Travel / Business Partnership / Earnings Announcement / /FacilityCasali Institute of Applied Chemistry / The Silberman Institute of Life Sciences / The Hebrew University of Jerusalem / Hebrew University / Hebrew University of Jerusalem / haDassah universitY hosPital / The Hebrew University of Jerusalem Mr. Matan Rapoport / The Hebrew University / Development The Hebrew University / The Hebrew University of Jerusalem Tailor-Made Biodegradable Polymers / The Hebrew University of Jerusalem The Authority / The Hebrew University of Jerusalem Matan / University of Washington / The Robert H. Smith Institute of Plant Sciences / Silberman Institute of Life Sciences / The Hebrew University of Jerusalem Mr. Nadav Kimelman-Bleich / The Institute of Chemistry / The Hebrew University of Jerusalem Dr. Dagan / / /IndustryTermlenticular printing software industry / substantial generic pharmaceutical / biomedical systems / food / energy / antisense technology / therapy for mitochondrial disorders / real time using bioluminescence imaging / Pre-mRNA processing events / technology transfer / nerve gas / clinical applications / marketed profit-generating products / web-based software / energy production / drug delivery technology / therapeutic tools / food security / treatment of mitochondrial disorders / platform technology / life science venture capital / non-pharmaceutical applications / interactive search engines / imaging / statistical tools / statistical methods / human healthcare / treatment of the autoimmune disease / omni-stereo technology / neuronal pre-mRNA processing / chemical warfare / healthcare / medical applications / nerve gas poisoning / synthetic oxygen carrier supplementation / venture capital investors / /MedicalConditionlipoamide dehydrogenase deficiency / mitochondrial disorders / male infertility / metabolic disorders / tumor / diabetes / diseases / deficiency / LAD deficiency / disorders / rare and complex sphingolipid storage disorders / mitochondrial and metabolic disorders / muscle fatigue / nerve gas poisoning / nervous system poisoning / neurodegenerative disorders / neurological disease / cardiac injury / LAD deficiency disorder / anti-cholinesterase poisoning / insecticide poisoning / blood cell diseases / mitochondrial metabolic disorder / selectively killed cancers / disorder / mitochondrial disorder lipoamide dehydrogenase / cancer / AIDS / irritation / scar / liver failure / neuromuscular disease / myasthenia gravis / inherited recessive disorder / stress-induced diseases / autoimmune disease / /MedicalTreatmentheart surgery / neurosurgery / gene therapy / enzyme replacement therapy / open heart surgery / /OrganizationUniversity of Washington / School of Engineering and Computer Science / Department of Biological Chemistry / NIH National Science Foundation / haDassah universitY hosPital in Jerusalem / columBia universitY in new York / Faculty of Agricultural / Food and Environmental Quality Sciences / Faculty of Agriculture / FDA / Hebrew University of Jerusalem / Hebrew University / Institute of Chemistry / Authority for Research and Development / israeli ministrY / DePartment of BiochemistrY DailY anD suPervises stuDents / School of Pharmacy / universitY's facultY of meDicine anD / Department of Biochemistry / Casali Institute of Applied Chemistry / Board of Governors / Hebrew University of Jerusalem Matan / Faculty of Science / israeli council / israeli societY of BiochemistrY / United States Army / rockefeller universitY / Faculty of Dental Medicine / Haya Lorberboum-Galski / Robert H. Smith Institute of Plant Sciences and Genetics / Faculty of Medicine / Department of Cellular Biochemistry and Human Genetics / Hebrew University of Jerusalem Tailor-Made Biodegradable Polymers for the Prevention of Post-Surgical Adhesions Adhesions / Silberman Institute of Life Sciences / Hebrew University of Jerusalem Similar / University’s Board of Governors / Silberman Institute of Life Sciences and Dean / aDvisorY committee / /PersonNava Swersky / Nadav Kimelman-Bleich / Arie Dagan / Ester Neuroscience / Nadav Kimelman-Bleich Scaffolds / Daniel Cohn Tailor-made / Daniel Cohn / Shmuel Peleg / Dani Zamir / M. Ottolenghi / Matan Rapoport / Isaac Kaye / Shimon Gatt / Hermona Soreq / Yechezkel Barenholz / David Avnir / Dima Sheyn / Dan Gazit / Yaniv Semel / Simon Benita / Myrna Kaye Chair / S. Braun / Bleich / Lior / Hermona Soreq Engineered / Being / O. Lev / / /PositionProfessor of molecular BiologY anD / pharmaceutical chemist / PresiDent / elements stabilizing messenger / market leader / Chairman / President & CEO / reporter / /ProductCationorm / Doxil / Monarsen / REPELCV® Adhesion Barrier / /ProvinceOrStateNew Jersey / /PublishedMediummolecular BiologY / the DePartment of BiochemistrY DailY / /TechnologyBMP / antisense technology / apoptosis / drug delivery / neurosurgery / gene therapy / drug delivery technology / platform technology / gene delivery / stem cells / human genome / tissue engineering / gene expression / bioinformatics / ultrasound / omni-stereo technology / Hebrew University Technology / drug development / regenerative medicine / /URLwww.janisdesign.net / http /SocialTag |